Cochleovestibular Signs As the First Manifestation of Fabry Disease: A Case Report and Literature Review
- PMID: 38690505
- PMCID: PMC11058903
- DOI: 10.7759/cureus.57289
Cochleovestibular Signs As the First Manifestation of Fabry Disease: A Case Report and Literature Review
Abstract
Fabry disease (FD) is an X-linked lysosomal storage disorder characterized by alpha-galactosidase A deficiency, resulting in globotriaosylceramide accumulation and diverse clinical manifestations. We report a case of a 22-year-old male presenting with cochleovestibular disorders as the initial FD manifestation, alongside a literature review. Diagnostic evaluation revealed reduced alpha-galactosidase A activity, confirming FD. Cochleovestibular involvement, although underexplored, significantly affects FD patients, often presenting with sudden deafness or sensorineural hearing loss. Prompt diagnosis and enzyme replacement therapy are crucial for managing FD. Otolaryngologists play a key role in early detection and intervention. This case underscores the importance of considering FD in cases of hearing loss, tinnitus, or vertigo, emphasizing the need for heightened awareness among healthcare providers.
Keywords: acroparesthesia; angiokeratomas; fabry disease; fabry's disease; hearing loss; tinnitus.
Copyright © 2024, Zakaria et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Anderson-Fabry disease: a multiorgan disease.Curr Pharm Des. 2013;19(33):5974-96. doi: 10.2174/13816128113199990352. Curr Pharm Des. 2013. PMID: 23448451 Review.
-
Inner ear involvement in Fabry disease: Clinical and audiometric evaluation of a large cohort of patients followed in a reference centre.Eur J Med Genet. 2018 Jun;61(6):341-347. doi: 10.1016/j.ejmg.2018.01.006. Epub 2018 Jan 4. Eur J Med Genet. 2018. PMID: 29307789
-
Cochleovestibular manifestations in Fabry disease: Importance of screening and systematic ENT evaluation.Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Sep;136(4):273-279. doi: 10.1016/j.anorl.2019.04.014. Epub 2019 May 7. Eur Ann Otorhinolaryngol Head Neck Dis. 2019. PMID: 31072727
-
An Atypical Presentation of Fabry Disease in a Patient With Nephrotic Syndrome: A Case Report.Cureus. 2024 Jul 2;16(7):e63661. doi: 10.7759/cureus.63661. eCollection 2024 Jul. Cureus. 2024. PMID: 39092329 Free PMC article.
-
Genetics and Gene Therapy of Anderson-Fabry Disease.Curr Gene Ther. 2018;18(2):96-106. doi: 10.2174/1566523218666180404161315. Curr Gene Ther. 2018. PMID: 29618309 Review.
References
-
- Desnick RJ, Ioannou YA, Eng CM. The online metabolic and Molecular Bases of Inherited Disease. New York, US: McGraw-Hill Education; 2019. A-galactosidase a deficiency: Fabry disease.
-
- Keshav S. Fabry disease: perspectives from 5 years of FOS. Oxford: Oxford PharmaGenesis; 2006. Gastrointestinal manifestations of Fabry disease.
-
- Hearing loss in Fabry disease: data from the Fabry Outcome Survey. Hegemann S, Hajioff D, Conti G, et al. Eur J Clin Invest. 2006;36:654–662. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials